Data Updates in the Treatment of Resectable Cutaneous Squamous Cell Carcinoma (CSCC)

home / peer-exchange / data-updates-in-the-treatment-of-resectable-cutaneous-squamous-cell-carcinoma

Expert panelists review updated data in the identification and management of resectable cutaneous squamous cell carcinoma and reflect on how real-world practice has evolved.

EP. 1: Cutaneous Squamous Cell Carcinoma: Incidence and Risk Factors

By Nikhil Khushalani, MD
Martin Dietrich, MD, PhD, Florida Cancer Specialists and Research Institute

March 15th 2023

Opening their discussion on resectable cutaneous squamous cell carcinoma (CSCC), expert panelists elucidate its current incidence and known risk factors.

EP. 2: Available Staging Systems for Cutaneous Squamous Cell Carcinoma

By Nikhil Khushalani, MD
Martin Dietrich, MD, PhD, Florida Cancer Specialists and Research Institute

March 15th 2023

A review of current staging systems used to categorize CSCC, particularly those from the American Joint Committee on Cancer and Brigham and Women's Hospital.

EP. 3: Optimal Risk Stratification in Patients With Cutaneous Squamous Cell Carcinoma

By Nikhil Kushalani, MD
Martin Dietrich, MD, PhD, Florida Cancer Specialists and Research Institute

March 22nd 2023

Expert panelists share their perspectives on best strategies to risk stratify patients diagnosed with cutaneous squamous cell carcinoma.

EP. 4: Defining Resectability in CSCC

By Nikhil Kushalani, MD
Martin Dietrich, MD, PhD, Florida Cancer Specialists and Research Institute

March 22nd 2023

Following their discussions on staging and risk stratification in CSCC, key opinion leaders work to define resectability in cutaneous squamous cell carcinoma.